ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma

Xuetao Zhao,1 Congrong Yang,2 Jianhua Wu,3 Yuemin Nan4 1Department of Blood Transfusion, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People&...

Full description

Bibliographic Details
Main Authors: Zhao XT, Yang CR, Wu JH, Nan YM
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/adamts8-targets-erk-to-suppress-cell-proliferation-invasion-and-metast-peer-reviewed-article-OTT
id doaj-bd85d38f564b4fd7bb05f18e3e2341e9
record_format Article
spelling doaj-bd85d38f564b4fd7bb05f18e3e2341e92020-11-24T22:06:36ZengDove Medical PressOncoTargets and Therapy1178-69302018-10-01Volume 117569757841835ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinomaZhao XTYang CRWu JHNan YMXuetao Zhao,1 Congrong Yang,2 Jianhua Wu,3 Yuemin Nan4 1Department of Blood Transfusion, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 3Animal Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 4Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China Introduction: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system. A disintegrin and metallopeptidase with thrombospondin motif (ADAMTS) has been identified as a secreted metalloproteinase that participates in the inhibition of tumor cell growth and invasion. The aims of the present study were to investigate the clinical significance of ADAMTS8 in patients with HCC and to determine the effect of ADAMTS8 on HCC cell biological activity in vitro and in vivo.Methods: The tumor tissues and matched adjacent non-tumor tissues were collected from 61 patients with HCC, and ADAMTS8 expression was detected with immunohistochemistry. Flow cytometry and MTT assays were used to assess cell apoptosis and cell viability, respectively, and ERK, p-ERK, Stat3, p-Stat3, Akt, and p-Akt protein expressions were measured by Western blot.Results: The results showed that ADAMTS8 expression was significantly lower in HCC tissues than that in adjacent non-tumor tissues. Moreover, ADAMTS8 expression was inversely associated with clinical stages and metastasis in patients with HCC. Furthermore, we found that transfection with exogenous ADAMTS8 inhibited proliferation and migration and induced apoptosis in HepG2 cells. In the in vivo study, tumor growth of upregulated HepG2 cells in nude mice was significantly slower. Moreover, decreased ERK activity was detected after transfection with ADAMTS8.Conclusion: These results indicate that low ADAMTS8 expression is a predictor of a poor prognosis in patients with HCC and that ADAMTS8 plays an important role in regulating HCC growth, invasion, and apoptosis by modulating the ERK signaling pathway. ADAMTS8 maybe a new target in HCC treatment. Keywords: hepatocellular carcinoma, ADAMT8, apoptosis, invasion and metastasis, signaling pathwayhttps://www.dovepress.com/adamts8-targets-erk-to-suppress-cell-proliferation-invasion-and-metast-peer-reviewed-article-OTTHepatocellular carcinoma (HCC)ADAMT8ApoptosisInvasion and metastasisSignaling pathway
collection DOAJ
language English
format Article
sources DOAJ
author Zhao XT
Yang CR
Wu JH
Nan YM
spellingShingle Zhao XT
Yang CR
Wu JH
Nan YM
ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
OncoTargets and Therapy
Hepatocellular carcinoma (HCC)
ADAMT8
Apoptosis
Invasion and metastasis
Signaling pathway
author_facet Zhao XT
Yang CR
Wu JH
Nan YM
author_sort Zhao XT
title ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
title_short ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
title_full ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
title_fullStr ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
title_full_unstemmed ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
title_sort adamts8 targets erk to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2018-10-01
description Xuetao Zhao,1 Congrong Yang,2 Jianhua Wu,3 Yuemin Nan4 1Department of Blood Transfusion, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 3Animal Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 4Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China Introduction: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system. A disintegrin and metallopeptidase with thrombospondin motif (ADAMTS) has been identified as a secreted metalloproteinase that participates in the inhibition of tumor cell growth and invasion. The aims of the present study were to investigate the clinical significance of ADAMTS8 in patients with HCC and to determine the effect of ADAMTS8 on HCC cell biological activity in vitro and in vivo.Methods: The tumor tissues and matched adjacent non-tumor tissues were collected from 61 patients with HCC, and ADAMTS8 expression was detected with immunohistochemistry. Flow cytometry and MTT assays were used to assess cell apoptosis and cell viability, respectively, and ERK, p-ERK, Stat3, p-Stat3, Akt, and p-Akt protein expressions were measured by Western blot.Results: The results showed that ADAMTS8 expression was significantly lower in HCC tissues than that in adjacent non-tumor tissues. Moreover, ADAMTS8 expression was inversely associated with clinical stages and metastasis in patients with HCC. Furthermore, we found that transfection with exogenous ADAMTS8 inhibited proliferation and migration and induced apoptosis in HepG2 cells. In the in vivo study, tumor growth of upregulated HepG2 cells in nude mice was significantly slower. Moreover, decreased ERK activity was detected after transfection with ADAMTS8.Conclusion: These results indicate that low ADAMTS8 expression is a predictor of a poor prognosis in patients with HCC and that ADAMTS8 plays an important role in regulating HCC growth, invasion, and apoptosis by modulating the ERK signaling pathway. ADAMTS8 maybe a new target in HCC treatment. Keywords: hepatocellular carcinoma, ADAMT8, apoptosis, invasion and metastasis, signaling pathway
topic Hepatocellular carcinoma (HCC)
ADAMT8
Apoptosis
Invasion and metastasis
Signaling pathway
url https://www.dovepress.com/adamts8-targets-erk-to-suppress-cell-proliferation-invasion-and-metast-peer-reviewed-article-OTT
work_keys_str_mv AT zhaoxt adamts8targetserktosuppresscellproliferationinvasionandmetastasisofhepatocellularcarcinoma
AT yangcr adamts8targetserktosuppresscellproliferationinvasionandmetastasisofhepatocellularcarcinoma
AT wujh adamts8targetserktosuppresscellproliferationinvasionandmetastasisofhepatocellularcarcinoma
AT nanym adamts8targetserktosuppresscellproliferationinvasionandmetastasisofhepatocellularcarcinoma
_version_ 1725822970537967616